TP53 and non-small cell lung carcinoma: Another study demonstrated that in non-small cell lung cancer (NSCLC), mutant p53 interacts with HIF-1α to form a complex, thereby enhancing the transcriptional activity of HIF-1α on hypoxia-responsive genes and promoting tumor progression.